Shattuck Labs, Inc.
STTK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680367
In the last 90 days, Shattuck Labs, Inc. insiders filed 0 open-market purchases and 1 sale; 100 institutions reported holding it in 13F filings for Q2 2026, worth $581.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Shattuck Labs, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 56 | 4 | 65 | +13 |
| Shares | 36.4M | 539.3K | 42.0M | +6.18M (+17.2%) |
| Value | $87.0M | $1.29M | $153.4M | +$67.7M (+79.0%) |
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Shattuck Labs, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| NEXTBio Capital Management LP | 3,149,907 | $11.5M | 6.74% |
| Price T Rowe Associates Inc | 1,926,140 | $7.03M | 0.00% |
| T. Rowe Price Investment Management, Inc. | 1,354,761 | $4.95M | 0.00% |
| Point72 Asset Management, L.P. | 1,068,231 | $3.90M | 0.01% |
| TD Asset Management Inc | 251,050 | $916.3K | 0.00% |
| Sphera Funds Management Ltd. | 195,212 | $712.5K | 0.15% |
| Manufacturers Life Insurance Company, The | 135,056 | $486.2K | 0.00% |
| Citadel Advisors LLC | 68,846 | $251.3K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 65,734 | $239.9K | 0.00% |
| EP Wealth Advisors, LLC | 41,167 | $150.3K | 0.00% |
| Invesco Ltd. | 28,231 | $103.0K | 0.00% |
| Omers Administration Corp | 26,500 | $96.7K | 0.00% |
| Dimensional Fund Advisors LP | 23,192 | $84.7K | 0.00% |
| Mallini Complete Financial Planning LLC | 22,632 | $82.6K | 0.07% |
| American Century Companies Inc | 17,282 | $63.1K | 0.00% |
| Ameriprise Financial Inc | 11,500 | $42.0K | 0.00% |
| Stoneridge Investment Partners LLC | 10,453 | $38.0K | 0.03% |
Sold out (4)
Institutions that held Shattuck Labs, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Virtu Financial LLC | 16,054 | $38.0K |
| Turtle Creek Wealth Advisors, LLC | 12,235 | $29.2K |
| AssuredPartners Investment Advisors, LLC | 10,000 | $23.9K |
| SRS Capital Advisors, Inc. | 14 | $33 |
Not filed for Q4 2025 yet (4)
Institutions that held Shattuck Labs, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Takeda Pharmaceutical Co Ltd | 515,619 | $1.23M |
| Point72 Asia (Singapore) Pte. Ltd. | 14,454 | $34.5K |
| Cubist Systematic Strategies, LLC | 8,863 | $21.2K |
| Point72 (DIFC) Ltd | 370 | $884 |